tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

RPRX Stock Latest News

Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Press ReleasesRoyalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
29d ago
RPRX
Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes
PremiumPress Releases
Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes
30d ago
RPRX
Agios Pharmaceuticals price target raised to $53 from $44 at RBC Capital
PremiumThe Fly
Agios Pharmaceuticals price target raised to $53 from $44 at RBC Capital
30d ago
AGIO
RPRX
Royalty Pharma downgraded to Neutral from Buy at UBS
PremiumThe Fly
Royalty Pharma downgraded to Neutral from Buy at UBS
30d ago
RPRX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
AGIO
ARCT
Royalty Pharma, Agios enter into vorasidenib royalty agreement
PremiumThe FlyRoyalty Pharma, Agios enter into vorasidenib royalty agreement
1M ago
AGIO
RPRX
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
PremiumPress Releases
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
1M ago
RPRX
Agios Pharmaceuticals announces $905M purchase agreement for vorasidenib royalty
PremiumThe Fly
Agios Pharmaceuticals announces $905M purchase agreement for vorasidenib royalty
1M ago
AGIO
RPRX
Cytokinetics price target lowered to $70 from $92 at Raymond James
PremiumThe Fly
Cytokinetics price target lowered to $70 from $92 at Raymond James
1M ago
CYTK
RPRX
Cytokinetics price target lowered to $72 from $108 at Needham
PremiumThe Fly
Cytokinetics price target lowered to $72 from $108 at Needham
1M ago
CYTK
RPRX
Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
PremiumPress Releases
Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
1M ago
RPRX
Cytokinetics and Royalty Pharma expand funding deal up to $575M
PremiumThe Fly
Cytokinetics and Royalty Pharma expand funding deal up to $575M
1M ago
CYTK
RPRX
Royalty Pharma to Present at Upcoming Investor Conferences
PremiumPress ReleasesRoyalty Pharma to Present at Upcoming Investor Conferences
2M ago
RPRX
Royalty Pharma to acquire royalty interest in Sanofi’s frexalimab
PremiumThe Fly
Royalty Pharma to acquire royalty interest in Sanofi’s frexalimab
2M ago
SNY
RPRX
Royalty Pharma sees 2024 Porfolio Receipts $2.6B-$2.7B
PremiumThe Fly
Royalty Pharma sees 2024 Porfolio Receipts $2.6B-$2.7B
2M ago
RPRX
Royalty Pharma reports Q1 revenue $568M, consensus $663.22M
PremiumThe Fly
Royalty Pharma reports Q1 revenue $568M, consensus $663.22M
2M ago
RPRX
Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
PremiumPress Releases
Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
2M ago
RPRX
Arrowhead earns $50M milestone from Royalty Pharma
PremiumThe Fly
Arrowhead earns $50M milestone from Royalty Pharma
2M ago
AMGN
ARWR
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
PremiumPress Releases
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
2M ago
RPRX
Royalty Pharma Declares Second Quarter 2024 Dividend
PremiumPress ReleasesRoyalty Pharma Declares Second Quarter 2024 Dividend
3M ago
RPRX
Royalty Pharma price target lowered to $38 from $40 at BofA
PremiumThe Fly
Royalty Pharma price target lowered to $38 from $40 at BofA
3M ago
RPRX
Ionis Pharmaceuticals price target raised to $72 from $65 at Oppenheimer
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $72 from $65 at Oppenheimer
4M ago
IONS
RPRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >